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In t roduct ion: Gastric cancer (GC) as the 3rd most com-
mon malignancy in Iran,  accounts for ~50% of all GI can-
cers who cause 55% of all cancer-related deaths in Iran.
The rates of GC reported from Ardabil province,  Iran,  are
among the highest in the world.  Upper gastrointestinal
cancer accounts for more than 50% of all cancer deaths in
this area.  Codon 72 polymorphism of the tumor suppres-
sor gene TP53 has been associated with a higher risk in
the development of several types of cancer.  The polymor-
phism results in a variant protein with either an arginine
(CGC) or a proline residue (CCC).  We aimed analyze the
association of the TP53 codon 72 polymorphism with the
risk of developing gastric cancer in a high-risk popula-
tion around the world.
Materials  and Methods: We enrolled 87 patients with
mean age 65.9 (range: 37-87; std.=11.1) affected with pri-
mary gastric cancer (GC) and same age- and sex-matched
healthy control participants.  The analysis has been done
by PCR-RFLP on DNA extractions from peripheral blood.  
Resul t s : In case group the genotype was 16.1%, 42.5%,
and 41.4% for Arg/Arg,  Arg/Pro,  and Pro/Pro,  respective-
ly.  And for controls those were 18.5%,  40.2%,  and
41.4%. In comparing case and control group,  no signifi-
cant correlation was found (p=0.9).  Also,  there was any
significant correlation between codon 72 status and
pathologic data.  
Conclus ion: Because of the high frequency of GC in our
province,  the investigations about the role of genetic sus-
ceptibilities for GC are very important.  In spite of finding
no relationship between P53 polymorphisms,  studying
other genetic variations is recommended.
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In t roduct ion: At present,  the origin of extra cellular DNA
in plasma (serum) in human blood by the release of living
cells do not arise any doubts.Therefore,  we currently focus
on the composition of these nucleic acids and their corre-
lation with different diseases or phases of the physiolog-
ical state of man.  Thus the use of analysis of extra cellular
DNA may have to address all four objectives of Laboratory
Medicine - screening,  diagnosis,  monitoring and fore-
casting.  For screening and as a noninvasive diagnostic
method it is possible to use definition of level of extra
cellular DNA and its predecessors-ASF (acid-soluble frac-
tion) in the blood of patients with renal pathology.In our
work we have distinguished two objectives: The study of
content of extra cellular DNA and ASF associated with ery-
throcytes in the blood of healthy individuals and patients
with common renal pathologies - chronic pyelonephritis
(CP)Previously,  it was found that an increased level of
nucleic acids in blood was observed in a number of can-
cers,  radiation damage,  autoimmune diseases,  aging and
pregnancy.  
Material  and Method: 50 Patients (age 25- 55 years)
with clinically verified CP and 50 healthy peoples were
included in the study.  Epidemiological data (as Personal,
family,  smoking and drinking history,  nutritional infor-
mation) and clinical pathological data were collected from
the medical records and face to face survey questionnaire
Their blood sample was collected for study of extra cellu-
lar DNA & ASF (Acid Soluble Fraction) by using
Marusheva L.E equilibrium test and spectrophotometery.  
Resul t : Our analysis shows an increase of ASF compared
with control by 2.02 times which represents a significant
decay of extra cellular DNA on its fragmentation,  since
endonuclease activity in blood significantly increased in
CP.The number of extra cellular DNA associated with ery-
throcytes is decreases by 2.18 times compared with con-
trol.This result confirms our data on the accelerated degra-
dation of extra cellular DNA in blood in CP.  
Conclus ion: Extra cellular DNA & ASF associated with
erythrocytes in blood of healthy people and in patients
with Chronic Pyelonephrit is  was differentiated by
increased level of ASF by 2.02 times & decreased level of
extra cellular DNA content by 2.18 times. .
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In t roduct ion: Apert syndrome is a genetic disease,  caused
by a mutation transmitted autosomal dominant gene
FGFR2 (location: 10q25-q26).  Major clinical manifesta-
tions include oxicefalie,  brachycephalism, hipertelorism,
protruding cardiovascular anomalies and genito-urinary
and musculoskeletal sindactilie.  Objective: This paper
aims at presenting a patient with Apert Syndrome,  focus-
ing on multidisciplinary aspects of disease management
(genetic screening,  pediatric,  orthopedic,  dental and neu-
rological),  and problems occurring in providing genetic
counseling.  The patient is the 3rd child of a couple young
mother 30 years,  father 36 years,  neconsangvin.
Pregnancy developed normally birth occurred at term, nat-
urally,  cranial presentation and postnatal development is
normal,  appropriate age of 1 month.  
Resul t s : Based on clinical picture and paraclinical Apert
Syndrome is suspected.  Certainly positive diagnosis:
molecular diagnosis,  identification of gene mutations in
FGFR2. 
In conclusion we mark the importance of clinical exami-
nation and radiological  diagnosis Syndrome Apert ,
patients requiring a multidisciplinary assessment (neuro-
surgeon,  radiologist,  oral-maxillo-facial surgery,  ortho-
pedic surgeon,  geneticist,  a psychiatrist) for preoperative
evaluation and identification of other malformations
associated / complications (hydrocephalus).
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